PharmaCyte Biotech (PMCB) Net Cash Flow (2009 - 2026)
PharmaCyte Biotech's Net Cash Flow came in at -$864,293 for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$1.99 million a year earlier.
PharmaCyte Biotech (PMCB) Net Cash Flow (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, PharmaCyte Biotech reported Net Cash Flow of $4.56 million; for FY2026 (ended Apr 30, 2026), it was $3.43 million.
- Net Cash Flow carries a five-year compound annual growth rate of 21.3% (FY2021 to FY2026).
- Going back by fiscal year, Net Cash Flow was -$35.01 million in FY2025, -$17.86 million in FY2024, -$17.35 million in FY2023 and $83.19 million in FY2022.
- The five-year range for quarterly Net Cash Flow is -$17.55 million (fiscal Q1 2025) to $85.98 million (fiscal Q2 2022).
- Business Quant data shows PMCB's Net Cash Flow at -$1.56 million (Q4 2026), $4.76 million (Q3 2026) and $2.23 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -4.12 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -3.52 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.21 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.81 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.41 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -799.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.26 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 843.00 Mn |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | -864,293.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -864,293.00 |
| Apr 30, 2026 | -1.56 Mn |
| Jan 31, 2026 | 4.76 Mn |
| Oct 31, 2025 | 2.23 Mn |
| Jul 31, 2025 | -1.99 Mn |
| Apr 30, 2025 | -1.21 Mn |
| Jan 31, 2025 | -4.46 Mn |
| Oct 31, 2024 | -11.80 Mn |
| Jul 31, 2024 | -17.55 Mn |
| Apr 30, 2024 | -11.03 Mn |
| Jan 31, 2024 | -12.22 Mn |
| Oct 31, 2023 | -1.24 Mn |
| Jul 31, 2023 | 6.62 Mn |
| Apr 30, 2023 | -4.60 Mn |
| Jan 31, 2023 | -4.32 Mn |
| Oct 31, 2022 | -5.26 Mn |
| Jul 31, 2022 | -3.17 Mn |
| Apr 30, 2022 | -1.24 Mn |
| Jan 31, 2022 | -298,645.00 |
| Oct 31, 2021 | 85.98 Mn |
PharmaCyte Biotech Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=PMCB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();